Changes in the gene activity of immune cells may help flag people who have multiple sclerosis or are likely to develop it, a ...

Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer ...

Global Cancer Antibody Drug Conjugates Market Will Surpass US$ 50 Billion By 2030 Says Kuick ResearchDelhi, Oct. 23, 2024 ...

The global cytotoxic drugs market is on the cusp of remarkable expansion, with projections indicating a substantial increase in market value to USD 18.3 billion by 2033, up from USD 16.3 billion in ...

Scientists have engineered CAR-T cells with on/off switches activated by existing drugs, enhancing safety in cancer therapy.

Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech ...

A partial clinical hold was placed on the registrational trial after results showed variance between squamous and ...

Older adults with metastatic cancer living in Mexico experience a high time toxicity burden, spending about 21% of their days ...

Tanya Gupta, MD, discusses the use of ado-trastuzumab emtansine for the treatment of patients with HER2-positive breast cancer.

Discovered 30 years ago, microRNAs are increasingly recognized as important regulators of cell physiology and human disease.

Under the revised agreement, both companies will co-develop four Radio-DARPin programs; each company will have the right to commercialize two ...

Tevogen is driven by a team of experienced industry leaders and scientists with drug development and global product launch experience. Tevogen’s leadership believes that accessible personalized ...